METHODS AND APPARATUS FOR NONINVASIVE ISCHEMIC CONDITIONING

• US 20100105993A1
• Filed: 11/23/2009
• Published: 04/29/2010
• Est. Priority Date: 05/23/2007
• Status: Abandoned Application

• Current Assignee: IC Therapeutics, Inc.
• Original Assignee: IC Therapeutics, Inc.
• Inventors: Yen, Albert Andrew, Hassan, Haider, Panthagani, David, Naghavi, Morteza
• Application Number:
  US12/601,509
• Publication Number:
  US 20100105993A1
• Time in Patent Office: Days
• US Class Current: 600/301
• CPC Class Codes: A61B 17/135 inflatable for measuring blood pressure A61B5/022; inflatable pressure pads A61F5/34
• CPC Class Codes: A61B 17/1355 Automated control means therefor
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20
• CPC Class Codes: A61B 5/022 by applying pressure to close blood vessels, e.g. against the skin; Ophthalmodynamometers
• CPC Class Codes: A61B 5/14539 for measuring pH
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/14551 for measuring blood gases
• CPC Class Codes: A61B 5/411 Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance

Abstract

A method for ischemic conditioning treatment in a patient is provided. Transient ischemia is caused by interrupting blood flow to a tissue and a response to the ischemic conditioning treatments is monitored and the ischemia and response thereto is adjusted and controlled based on the monitoring results.

Claims

1. A method for an ischemic conditioning treatment in a patient comprising:

causing ischemia by interrupting blood flow to a tissue,

sensing markers of one or more of ischemia, blood flow, and metabolism in the tissue, and

adjusting the ischemia based on the sensed results.

2. The method of claim 1, wherein the sensed markers of ischemia include one or more of tissue oxygenation, and levels of hemoglobin, and the sensed markers of metabolism include one ore more of lactate, pH, oxygen, carbon dioxide, ATP, ADP, adenosine, cytochrome oxidase, redox voltage, erythropoietin, bradykinin, and opioids.

3. The method of claim 1, wherein the adjusting of ischemia is a change of an extent, duration, frequency, or combinations thereof, of ischemia in each ischemic conditioning treatment.

4. The method of claim 1, further comprising monitoring of markers of response to the ischemic conditioning treatments.

5. The method of claim 4, wherein the monitoring of markers of response to the ischemic conditioning treatments changes or stops the extent, duration, frequency, or combinations thereof, of ischemic conditioning treatments.

6. The method of claim 1, wherein the monitoring of markers of ischemia is obtained from non-ischemic tissue

7. The method of claim 6, wherein the monitoring of markers of ischemia from non-ischemic tissue is monitoring of circulating blood lactate.

8. The method of claim 1, wherein multiple ischemic conditioning treatments are stacked to provide an increase in early and delayed SWOP protective effects.

9. The method of claim 1, wherein the monitoring is a measurement of pulse, blood flow, or combinations thereof.

10. The method of claim 1 wherein the tissue is the anticipated location of a tissue injury, including one or more of:

toxin induced peripheral neuropathy, a site of a surgical procedure, an anticipated pressure induced sores, a site of toxic shock, and a site of infection.

11. The method of claim 1 wherein the tissue is a donor or recipient tissue for a transplant, implant, graft, or combination thereof.

12. The method of claim 1 wherein the ischemic conditioning treatment is performed preoperatively, intraoperatively, postoperatively, and/or combinations thereof.

13. The method of claim 1 wherein the ischemic conditioning treatment is augmented with a supplemental therapy selected from the group consisting of:

heat, photo thermal energy, hypoxia, hypothermia, pressure, vital sign measures, blood pressure measures, vibration, pain management, treatment drugs including inhalational anesthetics, anti-inflammatory agents, compounds that increase the bioavailability of nitric oxide (NO), and combinations thereof.

14. A device for inducing ischemic conditioning, comprising:

an occluding member adapted to occlude a blood vessel and cause ischemia;

a sensor to monitor a response to the ischemic conditioning treatments, wherein the monitored response is one or more of markers of ischemia, blood flow and metabolism in a tissue distal to the occlusion;

a programmable controlling member to control frequency and duration of ischemia in a tissue according to an ischemic conditioning protocol based on the monitored response; and

a data storage member to store the ischemic conditioning protocol, monitored response, and/or combinations thereof.

15. The device of claim 14 wherein the sensor is capable of monitoring markers of ischemia such as tissue oxygenation;

markers of metabolism including lactate, pH, oxygen, carbon dioxide, ATP, ADP, adenosine, cytochrome oxidase, redox voltage, erythropoietin, bradykinin, opioids; and

markers of blood flow or pulse;

or combinations thereof.

16. The device of claim 14 wherein the programmable controlling member is programmed with an ischemic conditioning protocol based on a reference algorithm.

17. The device of claim 16 wherein the algorithm results from a multivariate prediction model of the extent of tissue ischemia during vessel occlusion based on one or more variables including variables selected from the group consisting of:

age, gender, body mass index, body fat percentage, basal metabolic rate, heart rate, limb circumference, and combinations thereof.

18. A device for inducing ischemic conditioning, comprising:

an occluding member adapted to occlude a blood vessel and cause ischemia;

a programmable controlling member to control frequency and duration of ischemia in a tissue according to a protocol based on an algorithm that is obtained from a multivariate prediction model of the extent of tissue ischemia during vessel occlusion; and

a data storage member to store the ischemic conditioning protocol, monitoring results, or combinations thereof.

19. The device of claim 18, wherein the algorithm is based on one or more variables comprising variables selected from the group consisting of:

age, gender, body mass index, body fat percentage, basal metabolic rate, heart rate, limb circumference, and combinations thereof.

20. The device of claim any one of claims 18 and 19, wherein the occluding member is an inflatable cuff.

21. The device of claim 18, wherein the ischemic conditioning protocol in the programmable controlling member is programmed by a separate device.

22. The device of any one of claims claim 18-21, further comprising a display to show the ischemic conditioning protocol, stored data, results of the ischemic conditioning, or combinations thereof.

23. The device of any one of claims 18-22, further comprising one or more additional measurement devices capable of measuring vital signs and/or blood pressure.

24. A method for an ischemic conditioning treatment in a patient comprising:

causing ischemia by interrupting blood flow to a tissue utilizing an controlled occluding device, wherein the blood flow is interrupted at least once in a period of 72 hours prior to an anticipated injury, surgical intervention, or medical intervention,

monitoring one or more of tissue markers of ischemia;

markers of metabolism; and

markers of blood flow or pulse in the patient, and

adjusting the extent, duration, frequency, or combinations thereof, of ischemia based on the monitoring results.

25. The method of claim 24, further comprising interrupting blood flow to a tissue at least once in a period of 72 hours after an injury, surgical intervention, or medical intervention.

26. The method of claim 24 wherein the sensed markers of ischemia include one or more of tissue oxygenation, and levels of hemoglobin, and the sensed markers of metabolism include one ore more of lactate, pH, oxygen, carbon dioxide, ATP, ADP, adenosine, cytochrome oxidase, redox voltage, erythropoietin, bradykinin, and opioids.